1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. KREBS BIOCHEMICALS & INDUSTRIES LTD.

Krebs Biochemicals & Industries Ltd.

NSE: KREBSBIO | BSE: 524518

Download real time

72.58 -2.04 (-2.73%)

43.77% Fall from 52W High

7,376 NSE+BSE Volume

NSE 09 May, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
9S
15W
1O
0T
156.5

Market Cap

Below industry Median
-6.4

PE TTM

Negative PE TTM
0.4

PEG TTM

PEG TTM is less than 1
-1.3

Price to Book

Negative Price to Book
1.1

Beta 1Year

High Volatility
Board Meeting
The next board meeting for Krebs Biochemicals & Industries Ltd. is on 20 May 2025 for the purpose of Audited Results See details


Board Meetings - Krebs Biochemicals & Industries Ltd.

The next board meeting for Krebs Biochemicals & Industries Ltd. is on 20 May 2025 for the purpose of Audited Results

Share
Ex-date Purpose Notes
20 May 2025 Audited Results -
04 Feb 2025 Quarterly Results & Others To Consider Other business matters.
11 Nov 2024 Quarterly Results & Other To Consider Other business matters.
07 Aug 2024 Quarterly Results -
21 May 2024 Audited Results -
12 Feb 2024 Quarterly Results -
08 Nov 2023 Quarterly Results -
09 Aug 2023 Quarterly Results -
24 May 2023 Audited Results -
03 Feb 2023 Quarterly Results -
10 Nov 2022 Quarterly Results -
01 Aug 2022 Quarterly Results -
23 May 2022 Audited Results -
12 Feb 2022 Quarterly Results -
09 Nov 2021 Quarterly Results -
22 Oct 2021 Preferential issue of shares -
30 Jul 2021 Quarterly Results -
27 May 2021 Audited Results -
30 Jan 2021 Quarterly Results -
05 Nov 2020 Quarterly Results -
07 Aug 2020 Quarterly Results -
15 Jun 2020 Audited Results -
05 Feb 2020 Others inter alia, to consider allotment of the following equity shares, warrants convertible into equity shares and preference shares of the Company.
01 Feb 2020 Quarterly Results -
02 Jan 2020 Preferential Issue of shares & Issue Of Warrants
02 Nov 2019 Quarterly Results -
09 Aug 2019 Quarterly Results -
20 May 2019 Audited Results -
25 Mar 2019 Others inter alia, to consider the following: 1. To consider and approve the allotment of shares subject to the approval of basis of allotment by the Stock Exchanges.
12 Feb 2019 Quarterly Results -
11 Jan 2019 Right Issue of Equity Shares -
30 Oct 2018 Quarterly Results -
30 Jul 2018 Quarterly Results & Rights issue -
25 May 2018 Audited Results -
13 Feb 2018 Quarterly Results -
13 Nov 2017 Quarterly Results -
10 Aug 2017 Quarterly Results -
26 May 2017 Audited Results -
09 Feb 2017 Quarterly Results -
07 Dec 2016 Quarterly Results -
14 Sep 2016 Quarterly Results -
12 Aug 2016 Others To consider and approve the Board's Report along with the annexures thereto and the Corporate Governance Report for the FY 2015-16.
28 May 2016 Audited Results Allotment of 680,000 equity shares to Mrs. Hemalata Ravi upon conversion of the warrants which were allotted on October 03, 2015.
12 Feb 2016 Quarterly Results -
09 Nov 2015 Quarterly Results -
03 Oct 2015 Others To consider and allot 650,000 equity shares and 680,000 warrants convertible to Equity shares of Rs. 10/- each on preferential basis.
13 Aug 2015 Quarterly Results & Others 1. Resignation of Dr. R. T. Ravi as Managing Director and will be continuing as Non-Executive Director and Chairman of the Company. 2. Appointment of Mr. Avinash Ravi as Managing Director of the Co.
23 May 2015 Audited Results -
09 May 2015 Allotment of Equity Shares Allotment of equity shares on preferential basis to IPCA Laboratories Limited (2,300,000 Equity Shares) and Pinky Ventures Private Limited (600,000 Equity Shares).
31 Mar 2015 Others Allotment of equity shares / warrants as approved in the EGM dated March 11, 2015 on preferential basis subject to receiving relevant approval from Exchanges.
13 Feb 2015 Quarterly Results -
28 Nov 2014 Quarterly Results & Others To consider and recommend the draft Directors Report for the period from July 1, 2013 to September 30, 2014 along With the draft Notice for the AGM of Co. for the yaer ended 30/9/2014
26 Sep 2014 To take note of the scrutinisers report To take note of the scrutinisers report on Postal Ballot and declaring the results.
13 Aug 2014 Quarterly Results -
15 May 2014 Quarterly Results -
13 Feb 2014 Quarterly Results -
08 Nov 2013 Quarterly Results -
26 Aug 2013 Audited Results -
15 May 2013 Quarterly Results -
12 Feb 2013 Quarterly Results -
12 Nov 2012 Quarterly Results -
14 Aug 2012 Quarterly Results -
17 May 2012 Quarterly Results -
11 Feb 2012 Quarterly Results -
14 Nov 2011 Quarterly Results (Revised)
09 Aug 2011 Quarterly Results (Revised)
30 May 2011 Audited Results -
02 Feb 2011 Quarterly Results (Revised)
29 Oct 2010 Quarterly Results -
21 Jul 2010 Quarterly Results -
24 May 2010 Audited Results -
27 Jan 2010 Quarterly Results -
26 Oct 2009 Quarterly Results -
30 Jul 2009 Quarterly Results & Others The Board shifted the registered office of the Company to 8-2-277/A, Plot No.130 , 4A, 4th Floor, Inwinex Towers, Road no.2, Banjara Hills, Hyderabad - 500034.
29 May 2009 Audited Results -
31 Jan 2009 Quarterly Results -
31 Oct 2008 Quarterly Results -
25 Jul 2008 Audited & Quarterly Results -
29 Apr 2008 Quarterly Results -
22 Jan 2008 Quarterly Results -
24 Oct 2007 Quarterly Results -
27 Jul 2007 Quarterly Results -
04 Jun 2007 Audited Results -
22 Feb 2007 Allotment of equity shares To consider and allot the 10,50,000 equity shares to M/s. Ranbaxy Laboratories Ltd.
15 Jan 2007 Quarterly Results & Others To approve the issue of 10,50,000 equity shares on preferential basis to M/s. Ranbaxy Laboratories Ltd at a price of Rs 85/- per share (including Rs 10 nominal value and Rs 75/- premium).
31 Oct 2006 Quarterly Results -
02 Sep 2006 To consider the issue of warrants Inter alia, to consider the issue of warrants for preferential allotment of equity shares to promoters and their nominees in terms of section 81(1A) of the Companies Act, 1956.
29 Jul 2006 Accounts -
22 Apr 2006 Quarterly Results -
31 Jan 2006 Quarterly Results -
29 Oct 2005 Quarterly Results -
30 Jul 2005 Quarterly Results -
09 Jun 2005 Dividend & Accounts -
29 Jan 2005 Quarterly Results -
28 Oct 2004 Quarterly Results -
31 Jul 2004 Quarterly Results -
29 May 2004 Dividend & Accounts -
31 Jan 2004 Quarterly Results -
29 Oct 2003 Quarterly Results (Revised)
31 Jul 2003 Quarterly Results -